Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model

Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model

A number of drug treatments are known to alter the dialogue between the gut microbiota and the immune system components in the digestive mucosa. Alterations in intestinal homeostasis are now well known to affect peripheral immune responses and favor the occurrence of a number of pathologies such as...

Full description

Saved in:
Bibliographic Details
Main Authors: Guillaume Sarrabayrouse, Corentin Joulain, Stéphanie Bessoles, Andrada S. Chiron, Amine M. Abina, Salima Hacein-Bey-Abina
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
EPO - erythropoietin
mucosal immunity
microbiota
mice model experiments
dysbiosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1465410/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items